| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.2 |